-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Danshensu
Category | SARS-CoV |
CAS | 76822-21-4 |
Description | Danshensu is an active component of Salvia miltiorrhiza that shows wide cardiovascular benefit. It suppresses the formation of reactive oxygen species and inhibits platelet adhesion and aggregation. It also protects myocardium from the reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. It increases production of collagenin Detroit 551 cells and attenuates the α-MSH-stimulated melanin production of B16 cells. It may be used as active ingredients in would healing, cosmetic treatments or treating hyperpigmentation. It significantly decreased the level of the marker enzymes (creatine kinase and lactate dehydrogenase) from the coronary effluents and myocardial infarction size in vitro. It also had ROS scavenging activity and boosted endogenous antioxidants such as SOD, CAT, MDA, GSH-PX and HO-1 activities by activating nuclear factor erythroid-2-related factor 2 (Nrf2) signaling pathway which was mediated by Akt and ERK1/2 in western blot analysis. It significantly lowered tHcy in rats with elevated tHcy. Danshensu is a natural compound, which can also be used in cosmetics material. |
Product Information
Synonyms | Danshensu;76822-21-4;Salvianic acid A;(R)-3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid;Dan shen suan A;Salianic acid A;(2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid;UNII-4GF33A5PAJ;DS-182;4GF33A5PAJ;Benzenepropanoic acid, alpha,3,4-trihydroxy-, (alphaR)-;CHEMBL4218391;DTXSID60469215;Benzenepropanoic acid, a,3,4-trihydroxy-, (aR)-;(2R)-3-(3,4-dihydroxyphenyl)lactic acid;(2~{R})-3-[3,4-bis(oxidanyl)phenyl]-2-oxidanyl-propanoic acid;(R)-3-(3,4-dihydroxyphenyl)lactate;Dan shen suan A;Salvianic acid A;SCHEMBL18469325;CHEBI:71572;DTXCID70420034;BCP28285;HY-N1913;BDBM50594969;MFCD09750417;s4741;AKOS006328573;AC-7985;CCG-266569;CS-5614;NCGC00507734-01;AS-67314;DA-52304;C22038;r-(+)-beta-(3,4-dihydroxyphenyl)-lactic acid;A865407;W-203757;Q10395557;BENZENEPROPANOIC ACID, .ALPHA.,3,4-TRIHYDROXY-, (.ALPHA.R)-;(R)-a,3,4-Trihydroxybenzenepropanoic acid; 3-(3',4'-Dihydroxyphenyl)-(2R)-lactic acid; Dan shen suan A; Salvianic acid A;Danshensu;TO9; |
IUPAC Name | (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid |
Molecular Weight | 198.17 |
Molecular Formula | C9H10O5 |
Canonical SMILES | OC1=C(C=CC(C[C@H](C(O)=O)O)=C1)O |
InChI | InChI=1S/C9H10O5/c10-6-2-1-5(3-7(6)11)4-8(12)9(13)14/h1-3,8,10-12H,4H2,(H,13,14)/t8-/m1/s1 |
InChIKey | PAFLSMZLRSPALU-MRVPVSSYSA-N |
Boiling Point | 481.5±40.0°C at 760 mmHg |
Melting Point | >270°C (dec.) |
Purity | >98% |
Density | 1.546±0.06 g/cm3 |
Solubility | Soluble in DMSO (Slightly), Water (Slightly) |
Appearance | Solid |
Shelf Life | 2 month in rt, long time |
Storage | Store at 2-8°C under inert atmosphere |